Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

17.6%

3 terminated/withdrawn out of 17 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

47%

8 trials in Phase 3/4

Results Transparency

69%

9 of 13 completed trials have results

Key Signals

1 recruiting9 with results

Enrollment Performance

Analytics

Phase 2
4(28.6%)
Phase 4
4(28.6%)
Phase 3
4(28.6%)
N/A
1(7.1%)
Phase 1
1(7.1%)
14Total
Phase 2(4)
Phase 4(4)
Phase 3(4)
N/A(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT06604520Phase 2Recruiting

Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia

Role: collaborator

NCT02558972Phase 2Terminated

Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)

Role: collaborator

NCT04891224Not ApplicableCompleted

Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression

Role: collaborator

NCT04510922Phase 4Completed

Lundbeck TOMs Orthostatic Hypotension

Role: collaborator

NCT03229174Phase 4Completed

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Role: collaborator

NCT02134366Phase 3Terminated

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Role: collaborator

NCT01160770Phase 3Completed

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome

Role: lead

NCT01128959Phase 3Completed

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Role: lead

NCT01451463Completed

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Role: collaborator

NCT01073579Completed

Sabril Patient Registry

Role: lead

NCT01278173Phase 4Completed

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Role: lead

NCT02127918Completed

Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment

Role: collaborator

NCT01413711Phase 4Withdrawn

An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms

Role: lead

NCT00162981Phase 2Completed

Clobazam in Subjects With Lennox-Gastaut Syndrome

Role: lead

NCT00518713Phase 3Completed

Clobazam in Patients With Lennox-Gastaut Syndrome

Role: lead

NCT00125138Phase 2Completed

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Role: lead

NCT01079351Phase 1Completed

A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

Role: lead

All 17 trials loaded